证券研究报告 | 行业周报 gszqdatemark 2025 07 13 年 月 日 传媒 Grok 4 正式发布，豆神教育推出 AI class 行情概览：本周（7.7-7.11）中信一级传媒板块上涨 3.22%。本周传媒板 块在游戏板块带动下继续上涨，临近中报期重视中报预期较好公司的投资机 会。2025 年下半年传媒继续看好游戏等基本面驱动板块，同时弹性方向看好 AI 应用及 IP 变现。AI 应用聚焦新应用的映射投资及部分较成熟应用的数据跟 踪，重点关注 AI 陪伴、AI 教育及 AI 玩具方向。IP 变现聚焦有 IP 优势及全产 业链潜力的公司，潮流玩具、影视内容等方向有机会。 板块观点与关注标的：1）游戏：重点关注 ST 华通、吉比特、恺英网络、巨 人网络、神州泰岳、心动公司等，关注完美世界、冰川网络、华立科技等；2） AI：豆神教育、盛天网络、上海电影、荣信文化、盛天网络、中文在线、易点 天下、视觉中国、盛通股份、焦点科技、世纪天鸿、佳发教育等；3）资源整 合预期：中视传媒、国新文化、广西广电、华智数媒、吉视传媒、游族网络 等；4）国企：慈文传媒、皖新传媒、中文传媒、南方传媒、凯文教育、大晟 文 ...

建议关注国内生成式大模型龙头科大讯飞；AI 硬件有望成为应用落地的新载体，建议关注萤石网络、虹软科技、 禾赛等；AI 相关功能打磨能够带动付费率、Arpu 值提升，建议关注迈富时等。 风险提示 行业竞争加剧的风险；技术研发进度不及预期的风险；特定行业下游资本开支周期性波动的风险。 本周观点 投资建议 敬请参阅最后一页特别声明 1 7 月 8 日，腾讯推出 3D 生成模型 Hunyuan3D-PolyGen，可支持生成面数上万的复杂几何模型。该模型拥有高 复杂度模型生成能力，可以实现面数适当、布线整洁的艺术级效果，满足游戏等场景对于细节的要求。目前，混 元 3D 团队还未发布混元 3D-PolyGen 的完整技术报告，但对其核心的原理和技术进行了简要介绍。整体上，该 模型采用了自回归网格生成框架，通过顶点与面片建模进行空间推理。7 月 10 日，马斯克在 xAI 发布会上发布 Grok 4，该模型在多个基准测试中取得了 SOTA。xAI 发布会上共发布了 Grok 4「单智能体版本」和 Grok 4 Heavy 「多智能体版本」。马斯克表示 Grok 4 在训练方面相较于 Grok 2 与 Grok 3 有大幅 ...

点评：根据国际通用的分级标准，智驾可分为L1至L5五个级别，其中L4可简单理解为在特定条件下， 驾驶员可"脱手脱眼脱脑"。比亚迪此次实现媲美L4级智能泊车，是智能驾驶细分场景的重要突破，显示 其技术跻身全球前列。同时，其安全兜底承诺也可增强用户信任。 职场中，35岁常成隐形分水岭。7月8日，长城汽车（601633）(SH601633)董事长魏建军在个人微博发布 视频《年方35》。公司同步开启"长城汽车35+专场招聘会"，面向全球35岁以上人才开启专场招聘。 长城汽车此举巧妙地将雇主品牌与产品品牌和公司品牌捆绑：借"35岁"话题引发社会共鸣的同时，以企 业自身35年发展史类比人才成长曲线，将"不甘躺平"的品牌精神植入消费者心智。 一方面，企业面向全球35岁以上人才开启专场招聘，能为专业团队注入经验型人才。另一方面，当企业 姿态与公众对职场公平的期待同频，便易催生"情感共鸣"，消费者更愿为理解自身价值的品牌投票。 当然，品牌承诺不能流于口号，比如岗位虚设或晋升通道阻滞。人们希望专场招聘不会沦为营销符号， 希望品牌关于35岁的种种宣言可以兑现和验证。毕竟，公众对企业的期待，从来不止于口号的热度，更 在于行动持续性的 ...

全球AI产业周报 为你精选过去一周（7.5-7.11）最值得关注的AI新闻和 国内外热门AI投融资事件 ，帮助大家及时了 解全球AI市场动向。 本周AI热点资讯 国内大事 上下滑动可查看长图 可灵AI推出可图2.1模型 7月10日，快手可灵AI上线可图2.1模型，在多个维度实现了全面升级，包括指令遵循能力的大幅提 升、人像美感和电影质感以及超180多种不同风格的响应能力，同时新模型还进一步增强了文字生成 效果。官方公布的数据显示，可灵AI已累计生成超3.44亿图片和1.68亿视频。 （界面新闻） 智元机器人回应拟赴港IPO：不属实 7月10日，有消息称智元机器人上市目的地为港交所且正在推进港股IPO事宜。对此，智元机器人对 记者表示，上述消息不属实，智元机器人暂无赴港上市明确计划。7月8日晚间，科创板上市公司上纬 新材发布公告称，智元机器人拟收购其控股权。（中证金牛座） 百川智能联合创始人谢剑将离职 百川智能技术联合创始人谢剑将离职。其离职原因尚未公开，下一步动向也暂无明确消息。谢剑硕士 毕业于武汉大学人工智能方向，2012 年获得硕士学位后加入百度，后在职攻读博士，并获得清华大 学计算机科学博士学位。他曾是 ...

Group 1 - The core issue highlighted is the existence of delays in sending and receiving transactions on the Polygon network associated with Coinbase [1]

Core Insights - The integration of generative AI and agentic AI in medical devices is transforming clinical workflows and patient care, with generative AI focusing on content creation and design optimization, while agentic AI enables autonomous decision-making based on real-time data [1][3] Group 1: AI Integration in Medical Devices - Generative AI is used to create synthetic medical images for training diagnostic tools, enhancing datasets [1] - Agentic AI supports predictive maintenance in medical equipment, reducing downtime through fault detection and automated service scheduling [3] - AI-powered tools like Nuance Communications's Dragon Ambient eXperience improve clinical documentation by transcribing doctor-patient conversations into structured notes [2] Group 2: Key Factors Driving AI Adoption - There is a rising demand for precision and personalized medicine, with AI enabling individualized diagnostics and treatments based on patient-specific data [5] - The regulatory environment is favorable, with over 700 AI-enabled devices approved by the FDA, significantly increasing from 2020 [6] Group 3: Medical Device Stocks to Watch - Boston Scientific Corporation (BSX) is investing in AI for improved procedural outcomes, with a projected 2025 sales growth rate of 16.4% and earnings expected to grow by 15.9% [8][7] - Johnson & Johnson (JNJ) employs AI in surgical robotics and digital surgery analytics, with a historical earnings growth rate of 5.5% and projected sales growth of 2.8% for 2025 [11][10] - GE HealthCare Technologies Inc. (GEHC) leads in FDA-cleared AI devices, with a projected sales growth rate of 3.2% for 2025 and a focus on enhancing imaging through AI solutions [13][12]

Financial Performance (LTM 1Q 2016) - Westlake Chemical Corporation reported Net Sales of $4335 million[6] - The company's EBITDA was $1217 million[6] - Net Income attributable to Westlake was $623 million[6] - Olefins contributed $822 million to EBITDA, representing 67% of the total[6] - Vinyls contributed $410 million to EBITDA, representing 33% of the total[6] Strategic Advantages and Growth Drivers - The company leverages a strong ethane and other NGL advantage due to fundamental structural advances in supply[13] - Significant product integration allows the company to capture the full value chain[13] - Westlake is well-positioned for continued profitable growth due to its ongoing financial strength and flexibility[13] - Westlake has one of the highest LDPE product mix percentages in North America[30] - Global PVC demand is growing, supporting exports[45]

Financial Performance - Westlake Chemical Corporation reported net sales of $6.936 billion and EBITDA of $1.291 billion [4] - Net income attributable to Westlake Chemical Corporation was $456 million [4] - Olefins contributed $750 million to EBITDA, representing 53% of the total, while Vinyls contributed $658 million, accounting for 47% [4] Strategic Acquisitions and Synergies - The acquisition of Axiall has created a diverse, vertically-integrated chemicals leader, enhancing margin stability and growth opportunities [7] - Westlake expects to realize $120 million in synergy savings and cost reductions in 2017, with a total of $200 million expected by 2018 [7] Ethylene and Feedstock Advantages - Westlake has a short position in ethylene, providing cost advantages in the coming years due to its all-ethane feedstock capability [11, 12] - The company's ethylene plants are fully capable of using ethane and have some NGL flexibility, with the European business (Vinnolit) providing further feedstock diversification [22] Polyethylene Product Mix - Westlake has an advantaged polyethylene product mix, with LDPE accounting for 58% and LLDPE for 42% of its capacity [24] - The company focuses on LDPE, which has a higher average margin advantage compared to other PE grades [24] PVC and Global Presence - The Axiall acquisition has given Westlake a global PVC presence with facilities in North America, Europe, and Asia [36] - Westlake/Vinnolit is a leading specialty PVC producer with a global capacity of approximately 4,000 KMT in 2016 [48]

Financial Performance - Westlake's Net Sales reached $7766 million[5] - The company's EBITDA was $1631 million[5] - Net Income attributable to Westlake was $601 million[5] - Olefins EBITDA was $796 million, accounting for 47% of the total[5] - Vinyls EBITDA was $915 million, representing 53% of the total[5] Strategic Initiatives and Growth - The acquisition of Axiall has created a diverse, vertically-integrated chemicals leader[8] - Westlake expects to realize $120 million in synergy savings and cost reductions in 2017 and a total of $200 million by 2018 from the Axiall acquisition[8] - Westlake has a polyethylene capacity of 2600 million lbs[13] Market Position and Advantages - Westlake is the second largest producer of PVC in North America and the third largest globally[47] - Westlake is the third largest producer of Chlor-Alkali in North America and the third largest globally[47] - Westlake has one of the highest LDPE product mix percentages in North America[29]

Financial Performance & Strategy - Westlake Chemical Corporation reported Net Sales of $7766 million, EBITDA of $1631 million, and Net Income of $601 million (attributable to WLK) for the Last Twelve Months (LTM) ending in 3Q 2017[5] - The company's EBITDA is split between Olefins (47% or $796 million) and Vinyls (53% or $915 million)[5] - The acquisition of Axiall is expected to enhance margin stability and synergy savings of $120 million are expected in 2017, with a total of $200 million by 2018[8] - Strategic investments and capital projects totaling over $6 billion have been made recently to drive integration and specialty focus[61] Market Position & Advantages - Westlake is a leading integrated plastics materials company, holding the 2 position in North American PVC capacity and 3 globally, as well as the 3 position in North American Chlor-Alkali capacity and 3 globally[8] - The company remains 1 in North American LDPE capacity[8] - Westlake has a short position in ethylene, providing cost advantages, and has NGL feedstock flexibility and infrastructure[12, 15] - Westlake has one of the highest LDPE product mix percentages in North America, with LDPE accounting for 58% and LLDPE accounting for 42% of its capacity[25] Global Presence & Demand - The Axiall acquisition provides Westlake with a global PVC presence, including facilities in North America, Europe, and Asia[37] - Global PVC demand is growing, with a CAGR of 3.1% from 2000-2016 and an expected CAGR of 3.2% from 2017-2021[54] Financial Discipline & Growth - Westlake is committed to maintaining solid investment-grade credit metrics and has been deleveraging since the Axiall acquisition[66] - Westlake Partners (WLKP) provides a lower cost of capital to fund growth, with four levers of distributable cash flow (DCF) growth[70]